Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients-Reference-Cited by-同舟云学术

Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

Published:2020-11-11 Issue:11 Volume:15 Page:e0242184
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Camprubí Daniel,Almuedo-Riera Alex^ORCID,Martí-Soler Helena^ORCID,Soriano Alex,Hurtado Juan Carlos^ORCID,Subirà Carme^ORCID,Grau-Pujol Berta^ORCID,Krolewiecki Alejandro^ORCID,Muñoz Jose

Abstract

Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference14 articles.

1. Remdesivir for the treatment of Covid-19—preliminary report;JH Beigel;New Engl J Med,2020

2. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review;JM Sanders;JAMA,2020

3. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro;L Caly;Antiviral Res.

4. Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency;C Chaccour;Am J Trop Med Hyg,2020

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. More Widespread use of Ivermectin for the Treatment of COVID-19 Infec-tion could have Saved Many;Current Organocatalysis;2023-10-10

2. Ivermectin as a Repurposed Drug for COVID‐19;Chemistry and Biological Activities of Ivermectin;2023-09-12

3. Ivermectin-induced bacterial gut dysbiosis does not increase susceptibility to Pseudomonas aeruginosa lung infection but exacerbates liver damage;Microbes and Infection;2023-05

4. Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection;GeroScience;2023-03-07

5. The Clinical Application of Ivermectin in COVID-19;Open Journal of Natural Science;2023